A carregar...

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) has entered the age of individual treatment, and increasing point mutations of specific oncogenes and rearrangement of some chromosomes are biomarkers used to predict the therapeutic effect of targeted therapy. At present, there is a consensus among clinicians that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fang, Shu, Wang, Zhehai
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4189714/
https://ncbi.nlm.nih.gov/pubmed/25302015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S69690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!